“When all of a sudden you have a new product that you’re supposed to give to your entire birth cohort, and you’ve got to pay $500 that may or may not get paid back, that’s just not financially viable,” said Sean O’Leary, a pediatric infectious-disease specialist at the University of Colorado School of Medicine.
“The results seen with tirzepatide are the best seen so far with any anti-obesity medication and are similar to results seen at one year with bariatric surgery,” Adam Gilden, MD, an associate professor and the associate director of the weight management and wellness clinic at the University of Colorado School of Medicine in Aurora, told Everyday Health last month when the findings were published. Dr. Gilden wasn’t involved in the recent study.
For over a decade the University of Colorado’s Center for Bioethics and Humanities, on the Anschutz Medical Campus, has housed a program on the legacy of health professional involvement in the Holocaust, because the long shadow of these medical crimes continues to influence contemporary ethics in health care and society. In the Nazi era, innumerable health professionals and institutions took leading roles in developing and implementing racist, antisemitic programs of mass murder.
In April of this year, Dr. Jacob Langston, chief resident PGY-5 in the department of radiation oncology at the University of Colorado Anschutz Medical Campus Aurora, and his colleagues published results from a study in the journal Lung Cancer, in which 12 patients with non-small cell lung cancer (NSCLC) were treated with tyrosine kinase inhibitors first before they proceeded to stereotactic radiotherapy.
“The latest research about cannabis use indicates that smoking and inhaling cannabis increases concentrations of blood carboxyhemoglobin (carbon monoxide, a poisonous gas), tar (partly burned combustible matter) similar to the effects of inhaling a tobacco cigarette, both of which have been linked to heart muscle disease, chest pain, heart rhythm disturbances, heart attacks and other serious conditions,” said Page, a professor in the department of clinical pharmacy and physical medicine/rehabilitation at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences in Aurora, Colorado.
"One advertiser falsely stated that ketamine was approved to treat depression, and then three falsely stated that ketamine was nonaddictive," Michael DiStefano, co-author of the study and an assistant professor in the Skaggs School of Pharmacy and Pharmaceutical Sciences on the Anschutz Medical Campus, told UPI in a telephone interview.
More than 50 million Americans suffer from chronic back pain — but a new drug-free groundbreaking treatment, pain reprocessing therapy, from researchers at the University of Colorado Anschutz Medical Campus, is helping patients and offering new hope. NBC’s Jacob Soboroff reports for TODAY.
“This is pretty remarkable,” says Rachel Davis, an associate professor of psychiatry and neurosurgery at the University of Colorado School of Medicine, who researches DBS but was not involved in the new study.
